# ğŸ§¾ Audit Notes: Drug GM vs HBC Sales Trends

## ğŸ—“ï¸ Audit Period
September 7 â€“ September 28, 2025  
Four-week snapshot of category performance.

---

## ğŸ“Š Observations

- **HBC Sales Stability**  
  HBC maintained consistent weekly growth, likely driven by seasonal demand and strong replenishment cycles.

- **Drug GM Decline**  
  Drug GM showed a downward trend, with notable dips in Weeks 3 and 4. Inventory delays and markdown fatigue may have contributed.

- **Promo Impact**  
  Week 1 saw a sharp HBC drop post-promotion, confirming short-term lift but limited retention.

---

## ğŸ” Actions Taken

- Reset Drug GM endcaps to feature top-selling SKUs.
- Flagged low-performing SKUs for markdown review.
- Coordinated with replenishment team to address GM inventory gaps.

---

## ğŸ“ˆ Metrics Tracked

- Weekly sales by category
- Percent change week-over-week
- Forecast notes tied to operational events

---

## ğŸ’¡ Insights

- HBCâ€™s stability offers a benchmark for GM recovery.
- Promo timing and SKU placement directly influence short-term lift.
- Inventory delays have measurable impact on GM performance.

---

## ğŸ§­ Next Steps

- Build dashboard to visualize trends and interventions.
- Draft resume bullet quantifying impact.
- Explore markdown strategy optimization for Drug GM.
